Millions of adults suffer from chronic back pain due to their lifestyles, which eventually disrupts routine efficiency. The USFDA recently approved a virtual reality-based device that uses cognitive behavior therapy to treat chronic lower back pain. This device is devoid of opioid usage or any other treatment for pain reduction . The virtual reality (VR) device was granted the Breakthrough Device Designation by the FDA, offering a significant advantage over the pre-existing treatment modalities. The approval was based on a double-blind, randomized control trial.
How was the study conducted? 1. The study was designed as: Double-blinded, randomized control trial Eight-week VR programs Total time frame: 8.5 months (2-weeks baseline assessment + 8-week VR program + post-treatment assessment + follow-up at one, two, and three months for the endpoints 2. The study included : A…
